Singapore Virtual Hospitals and Mobile Inpatient Care at Home (MIC@Home)

To replace the need for another large public hospital by allowing patients to be looked after at home by hospital medical teams.

They are looked after by hospital medical teams through videoconferencing and teleconferencing, or in person.

Blood pressure monitor, thermometer, walking frames, and any other necessary equipment.

Hospitals under the National University Health System (NUHS).

Around 9,000 hospital bed days were saved.

Severe bullous cellulitis.

The major advantages of the MIC@Home scheme are: 1) For patients, the comfort of their own home and home-cooked food instead of being in a hospital ward; 2) For hospitals, it relieves stress and frees up hospital beds; 3) For the nation, it reduces healthcare costs.

The eligibility criteria for the MIC@Home scheme include: 1) Patients being clinically stable and unlikely to require intensive hospital care; 2) Able to care for themselves independently or have sufficient caregiving support; 3) Having an internet connection to communicate with doctors and nurses.

The MIC@Home scheme differs from traditional hospital care in that patients can receive treatment in the comfort of their own home, with access to home-cooked food, rather than being confined to a hospital ward. This provides greater comfort and convenience for patients, as evidenced by the experience of Mr. Ong Jia Rong.

The MIC@Home scheme currently covers patients with skin infections, urinary tract infections, and congestive heart failure with fluid overload. The scheme will be expanded to include other areas such as paediatric medicine, obstetrics and gynaecology, rehabilitation medicine, and elective surgeries.

The passage states that under the MIC@Home scheme, patients will receive subsidies, insurance, and MediSave coverage in the same way they would if they were in a hospital. This ensures that patients can access the necessary financial support and coverage for their at-home treatment.

The passage indicates that the two-year MIC@Home sandbox trial was deemed a success, and the scheme is now being expanded to become mainstream from April onwards. The scheme is also noted to be practiced in many other countries, suggesting its potential for further growth and adoption.